We showed that lung cancer patients presenting high EZH2 mRNA levels or high KDM6B mRNA levels presented a significantly higher risk of early death (p = 3.4 ×10−5 and p = 4.8 × 10−5) compared to patients with lower EZH2 or KDM6B mRNA levels (Figure 1E–G). Here, KDM6B is linked to lung cancer.